Mr. Jim Durward reports

YMI MARKETING CAMPAIGN UPDATE

Ndatalyze Corp.'s marketing contractor, BelieveCo (formerly VenturePlay), has provided an interim update of the YMI marketing campaign progress. BelieveCo claims that after only one month, the media campaign has been performing incredibly and the data show that it is performing well over benchmarks.

Ndatalyze's president, Jim Durward, states: "We planned our work and we're working our plan. I'm very pleased that phase 1 of the marketing strategy has performed so well. As expected, prospective customers were driven to the YMI website and their in-site behaviour tracked to provide valuable knowledge into prepurchase behaviours during the purchase process. We will now incorporate this knowledge in phase 2 and increase the resolution of our behavioural data gathering to optimize the overall purchase process."

In the near term the corporation expects to expand the campaign by:

• Contracting social media influencers -- relevant influencers have been identified and outreach has begun;
• Incorporating social media boosts -- expected to begin before Nov. 30, 2022;
• Increasing the digital advertising spend -- expected before the end of November, 2022;
• Expanding the target geography to include all of Canada -- expected before Dec. 15, 2022.

The corporation further reports that an introductory price reduction occurred during phase 1 and that the small number of sales that occurred prior to the price reduction were refunded as a show of goodwill to those customers -- meaning the prereduction customers were effectively given free access to YMI. The refunds will not have a material effect on the corporation's financial statements. The campaign is fully financed by the corporation's existing cash balance.

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. The YMI division has developed a machine learning-based, on-line consumer mental health application based on the corporation's proprietary reference database consisting of over 1,200 biometric records complete with associated electroencephalogram (EEG) data. With installations worldwide, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI has only recently launched, and accordingly, the corporation cannot accurately predict if or when this application will become a cash flow generator.

We seek Safe Harbor.